Adicon Holdings Limited, an independent clinical laboratory in China backed by US global investment firm Carlyle, on Tuesday announced the completion of an $88 million funding round that will help it speed up its diagnostic testing business in the country.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
